Pages that link to "Q74420341"
Jump to navigation
Jump to search
The following pages link to Treatment of temporal arteritis with adrenal corticosteroids; results in fifty-five cases in which lesion was proved at biopsy (Q74420341):
Displaying 50 items.
- Aspirin as adjunctive treatment for giant cell arteritis (Q24194497) (← links)
- Aspirin as adjunctive treatment for giant cell arteritis (Q24198176) (← links)
- Polymyalgia rheumatica and corticosteroids: how much for how long? (Q33554548) (← links)
- Plasma viscosity or erythrocyte sedimentation rate in the diagnosis of giant cell arteritis? (Q33649151) (← links)
- Anterior ischaemic optic neuropathy. I. Terminology and pathogenesis (Q33996981) (← links)
- The ocular lesions of temporal arteritis (Q34213433) (← links)
- Visual manifestations of temporal arteritis (Q34449093) (← links)
- The treatment of giant cell arteritis (Q34461224) (← links)
- Occult giant cell arteritis: ocular manifestations (Q34465521) (← links)
- Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy (Q35150781) (← links)
- Stopping steroids in polymyalgia rheumatica and giant cell arteritis (Q35167736) (← links)
- Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort (Q35200098) (← links)
- Giant cell arteritis: Current treatment and management. (Q35746677) (← links)
- Glucocorticoid usage in giant cell arteritis over six decades (1950 to 2009). (Q35891153) (← links)
- Temporal arteritis developing during indomethacin therapy of polymyalgia rheumatica (Q35898679) (← links)
- Recurrent episodic blindness in cranial arteritis (Q35923803) (← links)
- Risk factors for early visual deterioration in temporal arteritis. (Q36226768) (← links)
- Morphological features of temporal arteritis. (Q36703104) (← links)
- Bone mineral content of the third lumbar vertebra during 18 months of prednisolone treatment for giant cell arteritis (Q36744067) (← links)
- Scleritis and temporal arteritis (Q36811408) (← links)
- Giant cell arteritis presenting as subclavian artery occlusion. A report of two cases (Q36811610) (← links)
- Ophthalmic features of giant cell arteritis (Q37031446) (← links)
- Treatment of polymyalgia rheumatica/giant cell arteritis (Q37031460) (← links)
- Prognosis of polymyalgia rheumatica and giant cell arteritis (Q37031463) (← links)
- Sudden blindness in cranial arteritis (Q37396830) (← links)
- An approach to the diagnosis and management of systemic vasculitis. (Q37673239) (← links)
- Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis--a prospective longitudinal study (Q38787301) (← links)
- Visual loss and other cranial ischaemic complications in giant cell arteritis (Q39416333) (← links)
- Giant cell arteritis (cranial arteritis, polymyalgia rheumatica) (Q39511471) (← links)
- Polymyalgia rheumatica and giant cell arteritis—Rational diagnosis and treatment predicated on disordered prostaglandin metabolism (Q39566853) (← links)
- Polymyalgia rheumatica and temporal arteritis. (Q39728471) (← links)
- Temporal Arteritis and Gangrene of the Tongue (Q40010232) (← links)
- Polymyalgia rheumatica, giant-cell arteritis and blindness: a review and case report (Q40035203) (← links)
- Antirheumatic drugs: clinical pharmacology and therapeutic use. (Q40300190) (← links)
- A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis (Q40353912) (← links)
- Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision (Q40555875) (← links)
- Giant cell arteritis. Epidemiology and treatment. (Q40754180) (← links)
- Visual system involvement in giant cell (temporal) arteritis (Q41468001) (← links)
- Current concepts in giant cell (temporal) arteritis (Q41650340) (← links)
- Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. (Q41924342) (← links)
- Giant cell arteritis: A rare cause of posterior vasculitis (Q43096337) (← links)
- Horton's disease in elderly patients aged over 75: clinical course, complications of corticotherapy. Comparative study of 164 patients. Towards a reduced initial dose (Q43709004) (← links)
- Benefits of corticosteroids in the treatment of Horton's disease and rhizomelic pseudopolyarthritis: advantages and inconveniences. A meta-analysis (Q43814374) (← links)
- On the effect of hydrocortisone acetate on cell metabolism in experimental intima proliferation of the rat aorta (Q44510936) (← links)
- Simple Horton's syndrome: modalities of treatment (Q44803013) (← links)
- Complicated Horton's syndrome: therapeutic modalities (Q44803016) (← links)
- Takayasu's arteriopathy with involvement of aortic valve and bacterial endocarditis (Q44881690) (← links)
- Glucocorticoids: importance in the treatment of vasculitis (Q46469656) (← links)
- Vasculitides Throughout History and Their Clinical Treatment Today (Q48863996) (← links)
- Profile of tocilizumab and its potential in the treatment of giant cell arteritis. (Q49215677) (← links)